Search Results - "Chae, Jei Keon"

Preventive percutaneous coronary intervention versus optimal medical therapy alone for the treatment of vulnerable atherosclerotic coronary plaques (PREVENT): a multicentre, open-label, randomised controlled trial by Park, Seung-Jung, Ahn, Jung-Min, Kang, Do-Yoon, Yun, Sung-Cheol, Ahn, Young-Keun, Kim, Won-Jang, Nam, Chang-Wook, Jeong, Jin-Ok, Chae, In-Ho, Shiomi, Hiroki, Kao, Hsien-Li, Hahn, Joo-Yong, Her, Sung-Ho, Lee, Bong-Ki, Ahn, Tae Hoon, Chang, Ki-Yuk, Chae, Jei Keon, Smyth, David, Mintz, Gary S, Stone, Gregg W, Park, Duk-Woo, Park, Seung-Jung, Ahn, Jung-Min, Kang, Do-Yoon, Yun, Sung-Cheol, Ahn, Young-Keun, Kim, Won-Jang, Nam, Chang-Wook Nam, Jeong, Jin-Ok, Chae, In-Ho, Shiomi, Hiroki Shiomi, Kao, Hsien-Li, Hahn, Joo-Yong, Her, Sung-Ho, Lee, Bong-Ki, Ahn, Tae Hoon, Chang, Ki-Yuk, Chae, Jei-Keon, Smyth, David, Mintz, Gary, Stone, Gregg, Park, Duk-Woo

“…Acute coronary syndrome and sudden cardiac death are often caused by rupture and thrombosis of lipid-rich atherosclerotic coronary plaques (known as vulnerable…”
Get full text

Safety and Efficacy of Everolimus-Eluting Bioresorbable Vascular Scaffold Versus Second-Generation Drug-Eluting Stents in Real-World Practice by Lee, Joo Myung, Joh, Hyun Sung, Choi, Ki Hong, Hong, David, Park, Taek Kyu, Yang, Jeong Hoon, Song, Young Bin, Choi, Jin-Ho, Choi, Seung-Hyuk, Jeong, Jin-Ok, Lee, Jong-Young, Choi, Young Jin, Chae, Jei-Keon, Hur, Seung-Ho, Bae, Jang-Whan, Oh, Ju-Hyeon, Chun, Kook-Jin, Kim, Hyun-Joong, Cho, Byung Ryul, Shin, Doosup, Lee, Seung Hun, Hwang, Doyeon, Lee, Hyun-Jong, Jang, Ho-Jun, Kim, Hyun Kuk, Ha, Sang Jin, Shin, Eun-Seok, Doh, Joon-Hyung, Hahn, Joo-Yong, Gwon, Hyeon-Cheol

“…The risk of device thrombosis and device-oriented clinical outcomes with bioresorbable vascular scaffold (BVS) was reported to be significantly higher than…”
Get full text

Low-Density Lipoprotein Cholesterol Level in Patients With Acute Myocardial Infarction Having Percutaneous Coronary Intervention (the Cholesterol Paradox) by Cho, Kyung Hoon, MD, Jeong, Myung Ho, MD, PhD, Ahn, Youngkeun, MD, PhD, Kim, Young Jo, MD, PhD, Chae, Shung Chull, MD, PhD, Hong, Taek Jong, MD, PhD, Seong, In Whan, MD, PhD, Chae, Jei Keon, MD, PhD, Kim, Chong Jin, MD, PhD, Cho, Myeong Chan, MD, PhD, Seung, Ki Bae, MD, PhD, Park, Seung Jung, MD, PhD

“…The relation between low-density lipoprotein (LDL) cholesterol levels and clinical outcomes after percutaneous coronary intervention (PCI) in patients with…”
Get full text

Usefulness of Myocardial Longitudinal Strain in Prediction of Heart Failure in Patients with Successfully Reperfused Anterior Wall ST-segment Elevation Myocardial Infarction by Lee, Sun Hwa, Lee, Sang Rok, Rhee, Kyoung Suk, Chae, Jei Keon, Kim, Won Ho

“…Acute myocardial infarction-related heart failure (HF) is associated with poor outcome. This study was designed to investigate the usefulness of global…”
Get full text

Effect of Pre-Procedural Beta-Blocker on Clinical Outcome after Percutaneous Coronary Intervention in Acute Coronary Syndrome: From the 2014 K-PCI Registry by Kim, Bum Sung, Eom, Sang-Youg, Kim, Sung Hea, Hwang, Hweung Kon, Park, Jong-Seon, Kim, Weon, Lee, Jun-Won, Rha, Seung-Woon, Kim, Geon Young, Lim, Sang Wook, Lee, Su Hun, Chae, Jei Keon, Woo, Seong-Ill, Bae, Jang-Whan, Kim, Hyun-Joong

“…The efficacy of pre-procedural beta-blocker use in patients with acute coronary syndrome (ACS) is not well established in the current percutaneous coronary…”
Get full text

Comparison of Clinical Outcomes Between Ticagrelor and Prasugrel in Patients With ST-Segment Elevation Myocardial Infarction　― Results From the Korea Acute Myocardial Infarction Registry-National Institutes of Health by Kim, Min Chul, Jeong, Myung Ho, Sim, Doo Sun, Hong, Young Joon, Kim, Ju Han, Ahn, Youngkeun, Ahn, Tae Hoon, Seung, Ki Bae, Choi, Dong-Ju, Kim, Hyo-Soo, Gwon, Hyeon Cheol, Seong, In Whan, Hwang, Kyoung-Kook, Chae, Shung Chull, Hur, Seung Ho, Cha, Kwang Soo, Oh, Seok Kyu, Chae, Jei Keon, Korea Acute Myocardial Infarction-National Institutes of Health Registry Investigators

“…Background:There is little information regarding comparison of ticagrelor and prasugrel in patients with ST-segment elevation myocardial infarction (STEMI). We…”
Get full text

Clinical profiles of patients with surgically resected pheochromocytoma and paraganglioma by Lee, Sun Hwa, Park, Jae-Hyeong, Lee, Ja-Yeon, Lee, Sang-Rok, Rhee, Kyoung-Suk, Chae, Jei-Keon, Kim, Won-Ho, Sul, Ji-Young, Oh, Jin Kyung, Kwon, Hee-Jin, Lee, Jae-Hwan, Seong, In-Whan

“…Pheochromocytoma and paraganglioma (PPGL) are catecholamine-producing tumors that can cause blood pressure (BP) elevation and cardiovascular complications…”
Get full text

A Randomized Comparison of Sirolimus- Versus Paclitaxel-Eluting Stent Implantation in Patients With Diabetes Mellitus by Lee, Seung-Whan, MD, PhD, Park, Seong-Wook, MD, PhD, FACC, Kim, Young-Hak, MD, PhD, Yun, Sung-Cheol, PhD, Park, Duk-Woo, MD, PhD, Lee, Cheol Whan, MD, PhD, Hong, Myeong-Ki, MD, PhD, Rhee, Kyoung-Suk, MD, PhD, Chae, Jei Keon, MD, PhD, Ko, Jae-Ki, MD, PhD, Park, Jae-Hyeong, MD, PhD, Lee, Jae-Hwan, MD, PhD, Choi, Si Wan, MD, Jeong, Jin-Ok, MD, PhD, Seong, In-Whan, MD, PhD, Cho, Yoon Haeng, MD, PhD, Lee, Nae-Hee, MD, PhD, Kim, June Hong, MD, PhD, Chun, Kook-Jin, MD, Kim, Hyun-Sook, MD, PhD, Park, Seung-Jung, MD, PhD, FACC

“…A Randomized Comparison of Sirolimus- Versus Paclitaxel-Eluting Stent Implantation in Patients With Diabetes Mellitus Seung-Whan Lee, Seong-Wook Park,…”
Get full text

Influence of obesity and metabolic syndrome on clinical outcomes of ST-segment elevation myocardial infarction in men undergoing primary percutaneous coronary intervention by Lee, Seung Hun, Jeong, Myung Ho, Kim, Ju Han, Kim, Min Chul, Sim, Doo Sun, Hong, Young Joon, Ahn, Youngkeun, Chae, Shung Chull, Seong, In Whan, Park, Jong Sun, Chae, Jei Keon, Hur, Seung Ho, Cha, Kwang-Soo, Kim, Hyo-Soo, Gwon, Hyeon Cheol, Seung, Ki Bae, Rha, Seung Woon

“…•About a third of obese ST-elevation myocardial infarction (STEMI) patients were metabolically healthy.•Presence of MetS was not associated with poor prognosis…”
Get full text

Manual thrombus aspiration during primary percutaneous coronary intervention: Impact of total ischemic time by Sim, Doo Sun, MD, PhD, Jeong, Myung Ho, MD, PhD, FACC, FAHA, FESC, FSCAI, FAPSIC, Ahn, Youngkeun, MD, PhD, FACC, Kim, Young Jo, MD, PhD, Chae, Shung Chull, MD, PhD, Hong, Taek Jong, MD, PhD, Seong, In Whan, MD, PhD, Chae, Jei Keon, MD, PhD, Kim, Chong Jin, MD, PhD, Cho, Myeong Chan, MD, PhD, Rha, Seung-Woon, MD, PhD, FACC, Bae, Jang Ho, MD, PhD, FACC, Seung, Ki Bae, MD, PhD, FACC, Park, Seung Jung, MD, PhD, FACC

“…Abstract Background The benefit of manual thrombus aspiration (TA) during primary percutaneous coronary intervention (PCI) remains uncertain, and the effect of…”
Get full text

Benefit of Percutaneous Coronary Intervention in Early Latecomers With Acute ST-Segment Elevation Myocardial Infarction by Sim, Doo Sun, MD, PhD, Jeong, Myung-Ho, MD, PhD, Ahn, Youngkeun, MD, PhD, Kim, Young Jo, MD, PhD, Chae, Shung Chull, MD, PhD, Hong, Taek Jong, MD, PhD, Seong, In Whan, MD, PhD, Chae, Jei Keon, MD, PhD, Kim, Chong Jin, MD, PhD, Cho, Myeong Chan, MD, PhD, Rha, Seung-Woon, MD, PhD, Bae, Jang Ho, MD, PhD, Seung, Ki Bae, MD, PhD, Park, Seung Jung, MD, PhD

“…The clinical benefit of percutaneous coronary intervention (PCI) is controversial in stable early latecomers with ST-segment elevation myocardial infarction…”
Get full text

Impact of low level of high-density lipoprotein-cholesterol sampled in overnight fasting state on the clinical outcomes in patients with acute myocardial infarction (difference between ST-segment and non-ST-segment-elevation myocardial infarction) by Ji, Mi Seon, MD, PhD, Jeong, Myung Ho, MD, PhD, FACC, FAHA, FESC, FSCAI, FAPSIC, Ahn, Young Keun, MD, PhD, FACC, Kim, Young Jo, MD, PhD, Chae, Shung Chull, MD, PhD, Hong, Taek Jong, MD, PhD, Seong, In Whan, MD, PhD, Chae, Jei Keon, MD, PhD, Kim, Chong Jin, MD, PhD, Cho, Myeong Chan, MD, PhD, Rha, Seung-Woon, MD, PhD, FACC, Bae, Jang Ho, MD, PhD, FACC, Seung, Ki Bae, MD, PhD, FACC, Park, Seung Jung, MD, PhD, FACC

“…Abstract Background Despite good treatment, there are residual risks in acute myocardial infarction (AMI) patients, and low level of high-density…”
Get full text

Clinical Safety of Drug-Eluting Stents in the Korea Acute Myocardial Infarction Registry by Lee, Sang Rok, Jeong, Myung Ho, Ahn, Young Keun, Chae, Shung Chull, Hur, Seung Ho, Kim, Young Jo, Seong, In Whan, Chae, Jei Keon, Hong, Taek Jong, Rhew, Jae Young, Cho, Myeong Chan, Bae, Jang Ho, Rha, Seung Woon, Kim, Chong Jin, Jang, Yang Soo, Park, Seung Jung, Korea Acute Myocardial Infarction Registry Investigators

“…Background Percutaneous coronary intervention (PCI) with drug-eluting stents (DES) may be useful in patients with acute myocardial infarction (AMI), but safety…”
Get full text

Impact of Total Occlusion of an Infarct-Related Artery on Long-Term Mortality in Acute Non-ST-Elevation Myocardial Infarction Patients Who Underwent Early Percutaneous Coronary Intervention by Kim, Min Chul, Ahn, Youngkeun, Rhew, Shi Hyun, Jeong, Myung Ho, Kim, Ju Han, Hong, Young Joon, Chae, Shung Chull, Kim, Young Jo, Hur, Seung Ho, Seong, In Whan, Chae, Jei Keon, Investigators, for the KAMIR

“…Some patients with non-ST-elevation myocardial infarction (NSTEMI) have a total occlusive infarct-related artery. However, the long-term prognosis of these…”
Get full text

Clinical Outcome of Unprotected Left Main Coronary Artery Disease in Patients With Acute Myocardial Infarction by Sim, Doo Sun, Ahn, Youngkeun, Jeong, Myung Ho, Kim, Young Jo, Chae, Shung Chull, Hong, Taek Jong, Seong, In Whan, Chae, Jei Keon, Kim, Chong Jin, Cho, Myeong Chan, Seung, Ki Bae

“…The clinical outcome of patients with acute myocardial infarction (MI) with unprotected left main coronary artery (LMCA) stenosis is not fully understood. We…”
Get full text

Optimal Duration of Dual Antiplatelet Therapy After Drug-Eluting Stent Implantation A Randomized, Controlled Trial by CHEOL WHAN LEE, AHN, Jung-Min, RHA, Seung-Woon, JEONG, Myung-Ho, LIM, Do-Sun, YOON, Jung-Han, HUR, Seung-Ho, CHOI, Yun-Seok, YANG, Joo-Young, LEE, Nae-Hee, KIM, Hyun-Sook, LEE, Bong-Ki, PARK, Duk-Woo, KIM, Kee-Sik, LEE, Seung-Uk, CHAE, Jei-Keon, CHEONG, Sang-Sig, SUH, Il-Woo, PARK, Hun-Sik, NAH, Deuk-Young, JEON, Doo-Soo, SEUNG, Ki-Bae, KEUN LEE, KANG, Soo-Jin, JANG, Jae-Sik, PARK, Seung-Jung, LEE, Seung-Whan, KIM, Young-Hak, PARK, Seong-Wook, SEUNGBONG HAN, LEE, Sang-Gon, SEONG, In-Whan

“…The risks and benefits of long-term dual antiplatelet therapy remain unclear. This prospective, multicenter, open-label, randomized comparison trial was…”
Get full text

Comparison of clinical outcomes between octogenarians and non-octogenarians with acute myocardial infarction in the drug-eluting stent era: Analysis of the Korean Acute Myocardial Infarction Registry by Yamanaka, Futoshi, MD, Jeong, Myung Ho, MD, PhD, FACC, FAHA, FESC, Saito, Shigeru, MD, FJCC, Ahn, Youngkeun, MD, Chae, Shung Chull, MD, Hur, Seung Ho, MD, Hong, Taek Jong, MD, Kim, Young Jo, MD, Seong, In Whan, MD, Chae, Jei Keon, MD, Rhew, Jay Young, MD, Chae, In Ho, MD, Cho, Myeong Chan, MD, Bae, Jang Ho, MD, Rha, Seung Woon, MD, Kim, Chong Jin, MD, Choi, Donghoon, MD, Jang, Yang Soo, MD, Yoon, Junghan, MD, Chung, Wook Sung, MD, Cho, Jeong Gwan, MD, Seung, Ki Bae, MD, Park, Seung Jung, MD

“…Abstract Background and purpose Octogenarians (age ≥ 80 years) with coronary artery disease constitute a high-risk group. However, octogenarian patients with…”
Get full text

Involvement of GADD153 and Cardiac Ankyrin Repeat Protein in Hypoxia-induced Apoptosis of H9c2 Cells by Han, Xue-Ji, Chae, Jei-Keon, Lee, Mi-Jin, You, Kyung-Ran, Lee, Byung-Ho, Kim, Dae-Ghon

“…Oxidative stress is the main cause of cardiac injury during ischemia/reperfusion but the molecular mechanism for this process is unclear. In this study, it was…”
Get full text

Drug-Eluting Stent Thrombosis During Perioperative Period by Rhee, Sang Jae, Yun, Kyeong Ho, Lee, Sang Rok, Chae, Jei-Keon, Nam, Chang-Wook, Jun, Dong-Hwan, Jeong, Jin-Won

“…Recently, the number of patients in whom a drug-eluting stent (DES) has recently been implanted and who need to undergo surgery or the most invasive procedure…”
Get full text

Safety and Efficacy of Second-Generation Everolimus-Eluting Xience V Stents Versus Zotarolimus-Eluting Resolute Stents in Real-World Practice by Park, Kyung Woo, MD, PhD, Lee, Joo Myung, MD, Kang, Si-Hyuck, MD, Ahn, Hyo-Suk, MD, Yang, Han-Mo, MD, PhD, Lee, Hae-Young, MD, PhD, Kang, Hyun-Jae, MD, PhD, Koo, Bon-Kwon, MD, PhD, Cho, Janghyun, MD, PhD, Gwon, Hyeon-Cheol, MD, PhD, Lee, Sung Yoon, MD, PhD, Chae, In-Ho, MD, PhD, Youn, Tae-Jin, MD, PhD, Chae, Jei Keon, MD, PhD, Han, Kyoo-Rok, MD, PhD, Yu, Cheol Woong, MD, PhD, Kim, Hyo-Soo, MD, PhD

“…Objectives This study sought to compare the safety and efficacy of the Xience V/Promus everolimus-eluting stent (EES) (Abbott Vascular, Temecula, California)…”
Get full text